Overview

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Status:
Completed

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

This is a Phase II screening study of lithium carbonate in ALS. The purpose of this study is to find out if lithium carbonate is safe to be used in people with ALS and if it can slow the progression of the disease. Since there is no placebo in this study, all patients will be taking lithium carbonate.

Phase:

Phase 2

Details

Lead Sponsor:

Forbes Norris MDA/ALS Research Center

Collaborator:

Muscular Dystrophy Association

Treatments:

Lithium Carbonate